The expression of insulin receptor substrate 1 and estrogen receptor as prognostic factor on breast cancer patient

Conclusion: ER and IRS-1 subgroups appear to be critical factors for the prediction of breast cancer recurrence. In particular, we suggest that the patients who have ER-positive and IRS-1-negative breast cancer undergo more aggressive treatment because they have poorer prognoses.

Source: Journal of Cancer Research and Therapeutics - June 29, 2018 Category: Cancer & Oncology Authors: Hyun Goo Kim Sang Uk Woo Hoon Yub Kim Gil Soo Son Jae Bok Lee Jeong Won Bae Ok Hee Woo Dae Sik Yang Jae Hong Seo Ae-Ree Kim Source Type: research